Search results for "novartis"

Swiss pharmaceutical giant Novartis reported a 43 percent drop in net profits in the third quarter to nearly $1.6 billion, weighed down by the cost of restructuring. The group’s turnover fell by four percent to $12.5...

For the first time in Bangladesh, gene therapy has been applied to treat the chronic neurological disease Spinal Muscular Atrophy (SMA). The National Institute of Neurosciences & Hospital (NINS) has reached a new milestone in medical...

Swiss pharmaceutical company Novartis is preparing to give away 100 doses of the world’s most expensive drug, which treats a rare childhood disorder, but its recipient selection process has drawn criticism. The company announced this week...

Novartis has received approval from the U.S. Food and Drug Administration for its Beovu drug to treat a cause of vision loss, the Swiss pharmaceuticals company said on Tuesday. Beovu injections are used to treat wet...

Novartis announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft as its strategic AI and data-science partner for this effort. The new lab aims to bolster Novartis...

Novartis announced that Marie-France Tschudin, currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed President, Novartis Pharmaceuticals. She will report to Vas Narasimhan, CEO Novartis, and will join the Executive Committee with immediate...

Novartis is buying dry-eye drug Xiidra from Takeda Pharmaceutical Co for up to $5.3 billion as the Swiss drugmaker refreshes its ophthalmic medicines portfolio with a potential blockbuster. The deal, announced early on Thursday, calls for...

Novartis announced an offer to acquire CellforCure from LFB. CellforCure, a French company, is one of the first and largest contract development and manufacturing organizations (CDMO) producing cell and gene therapies in Europe. Under the proposed...

Novartis announced that Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed CEO Novartis Oncology. She will report to Vas Narasimhan, CEO, Novartis, and will join the Executive Committee on...

Alcon, the global leader in eye care and a division of Novartis, today announced plans to locate its future global headquarters in the Canton of Geneva, Switzerland, following completion of its proposed spinoff from Novartis. Alcon’s...